Results 211 to 220 of about 555,062 (342)

Immunologic evaluation in the prognosis of acute lymphoblastic leukemia. A report from Childrens Cancer Study Group [PDF]

, 1981
S. Leikin, Donald R. Miller, H Sather, Vincent Albo, E Esber, A Johnson, N Rogentine, D Hammond   +7 more
openalex   +1 more source

T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia. [PDF]

Blood Adv
Ma J, Luong A, Doan A, Lin TY, Ji L, Wang CP, Yoon SJ, Rushing T, Duong A, Villa M, Parekh C.   +10 more
europepmc   +1 more source

Italian registry of patients off therapy after childhood acute lymphoblastic leukemia. Results after first phase of data collection [PDF]

, 1986
Maria Grazia Zurlo, Guido Pastore, Giuseppe Masera, Benedetto Terracin, Roberto G. Burgio, Adriana Ceci, G Digilio, Carlo Guazzelli, Riccardo Haupt, Margherita Lo Curto, Enrico Madon, Franco Mandelli, G Paolucci, Luigi Zanesco   +13 more
openalex   +1 more source

Acute lymphoblastic leukemia

HemaSphere, 2018
openaire   +2 more sources

Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20‐year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)

British Journal of Haematology, EarlyView.
We report the UK experience of autologous haematopoietic stem cell transplantation (AHSCT) for multiple sclerosis (MS) in 364 patients. In our observational study, transplant‐related mortality was 1.4%, Epstein–Barr virus reactivation occurred in 75.9%, while disability progression‐free survival was 83.5% at 2 years post‐AHSCT and 62.4% at 5 years.
Majid Kazmi, Paolo A. Muraro, Varun Mehra, Ian Gabriel, Eleonora De Matteis, Gavin Brittain, Alice Mariottini, Richard Nicholas, Eli Silber, Julia Lee, Rachel Pearce, Ruth Paul, Maria Pia Sormani, Alessio Signori, Victoria Potter, Eduardo Olavarria, Ram Malladi, Basil Sharrack, John A. Snowden   +18 more
wiley   +1 more source

5q deletion in childhood T-acute lymphoblastic leukemia at diagnosis: a case report. [PDF]

J Med Case Rep
Sbibih Y, Bensalah M, Slaoui M, Saddari A, Trougouty N, Berhili A, Seddik R.   +6 more
europepmc   +1 more source

Asynchronous antigen expression in B lineage acute lymphoblastic leukemia [PDF]

, 1988
CA Hurwitz, MR Loken, ML Graham, JE Karp, MJ Borowitz, DJ Pullen, CI Civin   +6 more
openalex   +1 more source

A prior status of graft‐versus‐host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation

British Journal of Haematology, EarlyView.
Summary Optimizing the effectiveness of donor lymphocyte infusion (DLI) for relapse after allogeneic stem cell transplantation (alloHSCT) has been challenging. We investigated whether the benefits of achieving full donor chimerism (FDC) and developing graft‐versus‐host disease (GVHD) after DLI are affected by a history of GVHD before DLI.
Claudia Mae Velasco, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Myles Nickolich, Hong Zheng, Seema Naik, Christopher Ehmann, Joseph Mierski, Brooke Silar, Caitlin Vajdic, Robert Greiner, Valerie Brown, Shin Mineishi, Hiroko Shike, Kentaro Minagawa   +16 more
wiley   +1 more source

The Inositol-5-Phosphatase SHIP1: Expression, Regulation and Role in Acute Lymphoblastic Leukemia. [PDF]

Int J Mol Sci
Ehm P, Jücker M.
europepmc   +1 more source

Histiocytic lymphoma fifteen years following remission of acute lymphoblastic leukemia [PDF]

, 1980
H Dosik, R Anon, SL Lee, AC Allen, M. Krishnamurthy   +4 more
openalex   +1 more source